We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session
Read MoreHide Full Article
Globus Medical, Inc. (GMED - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $28.86–$31.87 in the past one-month time frame, witnessed a sharp increase yesterday.
The company's shares rallied after the company reported year-over-year growth in third-quarter earnings and revenues.
The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Globus Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Is GMED going up? Or down? Predict to see what others think: Up or Down
More Stock News: This Is Bigger than the iPhone
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session
Globus Medical, Inc. (GMED - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $28.86–$31.87 in the past one-month time frame, witnessed a sharp increase yesterday.
The company's shares rallied after the company reported year-over-year growth in third-quarter earnings and revenues.
The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Globus Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Globus Medical, Inc. Price and Consensus
Globus Medical, Inc. Price and Consensus | Globus Medical, Inc. Quote
A better ranked stock in the Medical - Instruments industry is Luminex Corporation. which also carries a Zacks Rank #1 (Strong Buy) . You can see the complete list of today’s Zacks #1 Rank stocks here.
Is GMED going up? Or down? Predict to see what others think: Up or Down
More Stock News: This Is Bigger than the iPhone
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>